8-K
filed February 13, 2025, 6:59 PM ET
ticker ALUR
CIK 0001964979
regulatory
confidence high
sentiment positive
materiality 0.55
Allurion relaunches balloon in France after ANSM clearance; exploring combo GLP-1 trial
ALLURION TECHNOLOGIES, INC.
- ANSM cleared Allurion to resume sales of Allurion Balloon in France, effective immediately (Feb 13, 2025).
- France historically represented approximately 15% of Allurion's revenue.
- Company plans clinical trial combining balloon with GLP-1s to study prevention of muscle loss during GLP-1 therapy.
- Previous study: patients with balloon gained 5.6% lean body mass while losing 14% total weight over 4 months.
- Another study: 167 patients lost 15.7% weight with no change in muscle mass.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001193125-25-026187
- form_type
- 8-K
- ticker
- ALUR
- cik
- 0001964979
- company_name
- ALLURION TECHNOLOGIES, INC.
- filed_at
- 2025-02-13T23:59:59+00:00
- discovered_at
- 2026-05-14T18:03:05.669474+00:00
- generated_at
- 2026-05-26T22:26:37.035320+00:00
- sec_items
- ["8.01", "9.01"]
- event_type
- regulatory
- sentiment
- positive
- materiality_score
- 0.55
- calibrated_materiality_score
- 0.55
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001193125-25-026187
- json_url
- https://secwatch.observer/filing/0001193125-25-026187.json
- markdown_url
- https://secwatch.observer/filing/0001193125-25-026187.md
- text_url
- https://secwatch.observer/filing/0001193125-25-026187.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1964979/000119312525026187/0001193125-25-026187-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1964979/000119312525026187/d826753d8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
RICK
RCI Hospitality regains Nasdaq compliance after filing delayed Q1 10-Q
RCI HOSPITALITY HOLDINGS, INC.
June 1, 2026, 3:08 PM ET
regulatory
Items 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: regulatory
similar materiality
Filing page
SEC filing
SLXN
Silexion Therapeutics completes 1-for-10 reverse share split; warrants adjusted
Silexion Therapeutics Corp
May 29, 2026, 7:00 AM ET
regulatory
Items 3.03, 5.03, 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: regulatory
similar materiality
Filing page
SEC filing
JAGX
Jaguar Health regains Nasdaq Bid Price compliance; monitoring until May 2027
Jaguar Health, Inc.
May 27, 2026, 9:10 AM ET
regulatory
Items 7.01, 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: regulatory
similar materiality
Filing page
SEC filing
MBOT
Microbot Medical receives Israeli regulatory approval for LIBERTY System, first outside U.S.
Microbot Medical Inc.
May 26, 2026, 8:30 AM ET
regulatory
Items 7.01, 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: regulatory
similar materiality
Filing page
SEC filing
AVXL
Anavex receives Nasdaq delinquency notice for late 10-Q filing; deadline July 20, 2026
ANAVEX LIFE SCIENCES CORP.
May 22, 2026, 8:15 AM ET
regulatory
Items 3.01, 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: regulatory
similar materiality
Filing page
SEC filing
ADGM
Adagio submits PMA to FDA for vCLAS VT ablation system; trial shows 97.4% acute success
Adagio Medical Holdings, Inc.
May 21, 2026, 4:31 PM ET
regulatory
Items 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: regulatory
similar materiality
Filing page
SEC filing
CGTX
Cognition Therapeutics completes productive FDA meeting for zervimesine in DLB psychosis
COGNITION THERAPEUTICS INC
May 21, 2026, 7:34 AM ET
regulatory
Items 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: regulatory
similar materiality
Filing page
SEC filing
AWK
Kentucky-American Water files $17.7M rate case; shareholders approve charter amendment, equity plan
American Water Works Company, Inc.
May 15, 2026, 4:34 PM ET
regulatory
Items 5.02, 5.07, 5.03, 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: regulatory
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.